Alnylam Pharmaceuticals
ALNY
$149.60
Share price
1.16%
Change (1 day)
-27.45%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Stock price history for Alnylam Pharmaceuticals (ALNY)
Highest end of day price: $241.31 USD on 2022-12-21
Lowest end of day price: $3.95 USD on 2004-08-16
Stock price history of Alnylam Pharmaceuticals from 2004 to 2024
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Novartis NVS | $103.41 | 0.10% | 🇨🇭 Switzerland |
 Sanofi SNY | $49.60 | 0.21% | 🇫🇷 France |
 Regeneron Pharmaceuticals REGN | $984.28 | -0.04% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $133.75 | 0.82% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $2.07 | -0.48% | 🇺🇸 USA |
 OPKO Health
OPK | $1.31 | 0.38% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $17.01 | -0.47% | 🇮🇱 Israel |
 Arrowhead Pharmaceuticals
ARWR | $24.36 | 6.31% | 🇺🇸 USA |